California Stem Cell Agency Exaggerated Its Role in Funding Key Research

April 17, 2008

California’s stem cell agency overstated and hyped the importance of its funding in enabling clinical trials for a drug to treat a severe blood disorder, Consumer Watchdog said today, seriously undercutting the agency’s credibility and alienating those who support publicly funded stem cell research. (PRNewswire)